TECLens

· TECLens, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TECLens, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. [NA]

See pricing